Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM.

Matheson, Elizabeth C., Thomas, Huw, Case, Marian, Blair, Helen, Jackson, Rosanna K., Masic, Dino, Veal, Gareth, Halsey, Chris, Newell, Herbie, Vormoor, Josef and Irving, Julie A.E. (2019) Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica, 104. pp. 1804-1811. ISSN 0390-6078

[img]
Preview
PDF
SURE 11055 B9D94670-ED51-4256-9855-D2603371FF22.pdf - Accepted Version

Download (1MB) | Preview

Search Google Scholar

Abstract

epub ahead of print

Item Type: Article
Divisions: Faculty of Health Sciences and Wellbeing
Faculty of Health Sciences and Wellbeing > FHSW Executive
Depositing User: Michelle Marshall
Date Deposited: 21 Aug 2019 15:28
Last Modified: 04 Feb 2020 10:34
URI: http://sure.sunderland.ac.uk/id/eprint/11055

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year